Associated Papers
Targeted sequencing and integrative analysis to prioritize candidate genes in neurodevelopmental disorders.
Zhang Y et al.
Molecular Neurobiology, 2021
33860439 (PubMed )
Supplement: 12035_2021_2377_MOESM14_ESM.xlsx › NDD_probands__public_
Tissue-specific DNase I footprint analysis confirms the association of GATAD2B Q470* variant with intellectual disability.
Nikam V et al.
Journal of Genetics, 2021
GATAD2B-associated neurodevelopmental disorder (GAND): clinical and molecular insights into a NuRD-related disorder.
Shieh C et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2020
The NuRD complex and macrocephaly associated neurodevelopmental disorders.
Pierson TM et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 2019
GATAD2B Gene Microdeletion Causing Intellectual Disability Autosomal Dominant Type 18: Case Report and Review of the Literature.
Trubnykova M et al.
Molecular Syndromology, 2019
Prioritized High-Confidence Risk Genes for Intellectual Disability Reveal Molecular Convergence During Brain Development.
Liu Z et al.
Frontiers in Genetics, 2018
30279698 (PubMed )
Supplement: Table_2.XLS › Sheet1
Novel GATAD2B loss-of-function mutations cause intellectual disability in two unrelated cases.
Luo X et al.
Journal of Human Genetics, 2017
Recurrent de novo mutations implicate novel genes underlying simplex autism risk.
O'Roak BJ et al.
Nature Communications, 2014
25418537 (PubMed )
Supplement: NIHMS636245-supplement-2.xlsx › Sheet_1
GATAD2B loss-of-function mutations cause a recognisable syndrome with intellectual disability and are associated with learning deficits and synaptic undergrowth in Drosophila.
Willemsen MH et al.
Journal of Medical Genetics, 2013
Diagnostic exome sequencing in persons with severe intellectual disability.
de Ligt J et al.
The New England Journal of Medicine, 2012
Select a paper to view details